The global GI endoscopic guidewire market is likely to reach USD 584 million by 2027, growing at a CAGR of 7.3% over the forecast period (2021-2027) according to QuantAlign Research. Growing geriatric population, increasing adoption of minimally invasive therapies and presence of favorable medical reimbursement policies are projected to boost the market demand over the forecast period. However, lack of trained professionals may hinder the market growth over the coming years.

Endoscopic is a nonsurgical procedure that is used to examine a person’s digestive tract. It includes the insertion of a long, thin tube directly into the body to observe an internal organ or tissue in detail. It can also be used to carry out other tasks including imaging and minor surgery. Guidewires have become indispensable tools in diagnostic and therapeutic endoscopic in order to maintain access to a lumen or cavity and to facilitate advancement of several devices. These are usually used for the advancement of rigid and balloon dilators, feeding tubes, manometry catheters, stents, and during transmucosal pseudocyst drainage in the upper GI endoscopic.

Browse complete report with TOC :

Global GI Endoscopic Guidewire Market Demand Outlook, COVID-19 Impact, Trend Analysis by Material (Stainless Steel, Nitinol, Hybrid), by Indications (ERCP, Upper-GI Endoscopic, Endoscopic Ultrasound (EUS), Colonoscopy), by End Use, and Industry Estimates 2021-2027 –  “https://quantalignresearch.com/global-gi-endoscopy-guidewire-market-report “

Key insights: 

• Nitinol segment held the major share of the market in 2019, and the trend is expected to continue over the forecast period
• Upper-GI endoscopy was the largest segment in 2019, and is likely to witness a significant CAGR from 2020-2027
• Hospital segment accounted for the largest share of the market in 2019, while ambulatory surgical centers (ASC) is likely to witness a high CAGR over the coming years
• North America held the majority share of the global market in 2019, however Asia-Pacific is expected to grow at the fastest CAGR over the forecast period

Key players operating in the market include COOK MEDICAL Inc.; US Endoscopic, Inc.; Boston Scientific Corporation; CONMED Corporation; Olympus Corporation; MERIT MEDICAL SYSTEMS, INC.; HOBBS MEDICAL INC.; Medico’s-Hirata Inc.; Omnimed Ltd, SCITEC and Zhejiang Chuangxiang Medical Technology Co., Ltd.; among others.